Leflunomide toxicity — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Leflunomide toxicity
The timing, drug exposure and investigation pattern support Leflunomide toxicity. The alternatives share some symptoms but do not match the adverse-effect profile as closely. DMARD toxicity should be considered whenever new systemic symptoms develop during immunosuppressive therapy.
Reference: BNF; SPS DMARD monitoring guidance; BSR DMARD prescribing guideline